Your browser doesn't support javascript.
loading
Genome-Wide Analysis Unveils DNA Helicase RECQ1 as a Regulator of Estrogen Response Pathway in Breast Cancer Cells.
Lu, Xing; Redon, Christophe E; Tang, Wei; Parvathaneni, Swetha; Bokhari, Bayan; Debnath, Subrata; Li, Xiao Ling; Muys, Bruna R; Song, Young; Pongor, Lorinc S; Sheikh, Omar; Green, Andrew R; Madhusudan, Srinivasan; Lal, Ashish; Ambs, Stefan; Khan, Javed; Aladjem, Mirit I; Sharma, Sudha.
Affiliation
  • Lu X; Department of Biochemistry and Molecular Biology, College of Medicine, Howard University, Washington, DC, USA.
  • Redon CE; Developmental Therapeutics Branch, Laboratory of Molecular Pharmacology, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland, USA.
  • Tang W; Molecular Epidemiology Section, Laboratory of Human Carcinogenesis, CCR, NCI, NIH, Bethesda, Maryland, USA.
  • Parvathaneni S; Department of Biochemistry and Molecular Biology, College of Medicine, Howard University, Washington, DC, USA.
  • Bokhari B; Department of Biochemistry and Molecular Biology, College of Medicine, Howard University, Washington, DC, USA.
  • Debnath S; Department of Biochemistry, Faculty of Applied Medical Science, Umm Al-Qura University, Makkah, Saudi Arabia.
  • Li XL; Department of Biochemistry and Molecular Biology, College of Medicine, Howard University, Washington, DC, USA.
  • Muys BR; Regulatory RNAs and Cancer Section, Genetics Branch, CCR, NCI, NIH, Bethesda, Maryland, USA.
  • Song Y; Regulatory RNAs and Cancer Section, Genetics Branch, CCR, NCI, NIH, Bethesda, Maryland, USA.
  • Pongor LS; Oncogenomics Section, Genetics Branch, CCR, NCI, NIH, Bethesda, Maryland, USA.
  • Sheikh O; Developmental Therapeutics Branch, Laboratory of Molecular Pharmacology, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland, USA.
  • Green AR; Division of Cancer and Stem Cells, Nottingham Breast Cancer Research Centre, University of Nottingham Biodiscovery Institute, Nottingham University Hospitals, Nottingham, United Kingdom.
  • Madhusudan S; Division of Cancer and Stem Cells, Nottingham Breast Cancer Research Centre, University of Nottingham Biodiscovery Institute, Nottingham University Hospitals, Nottingham, United Kingdom.
  • Lal A; Division of Cancer and Stem Cells, Nottingham Breast Cancer Research Centre, University of Nottingham Biodiscovery Institute, Nottingham University Hospitals, Nottingham, United Kingdom.
  • Ambs S; Regulatory RNAs and Cancer Section, Genetics Branch, CCR, NCI, NIH, Bethesda, Maryland, USA.
  • Khan J; Molecular Epidemiology Section, Laboratory of Human Carcinogenesis, CCR, NCI, NIH, Bethesda, Maryland, USA.
  • Aladjem MI; Oncogenomics Section, Genetics Branch, CCR, NCI, NIH, Bethesda, Maryland, USA.
  • Sharma S; Developmental Therapeutics Branch, Laboratory of Molecular Pharmacology, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland, USA aladjemm@mail.nih.gov sudha.sharma@howard.edu.
Mol Cell Biol ; 41(4)2021 03 24.
Article de En | MEDLINE | ID: mdl-33468559
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein / Oestrogènes / RecQ helicases Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Mol Cell Biol Année: 2021 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein / Oestrogènes / RecQ helicases Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Mol Cell Biol Année: 2021 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique